NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-247 Cr | ₹-363 Cr | ₹35 Cr | ₹-186 Cr | ₹-251 Cr |
What is the latest Cash Flow from Financing Activities ratio of NATCO PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-247 Cr |
Mar2023 | ₹-363 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹-186 Cr |
Mar2020 | ₹-251 Cr |
How is Cash Flow from Financing Activities of NATCO PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-247 Cr | Negative | |
Mar2023 | ₹-363 Cr | Negative | |
Mar2022 | ₹35 Cr | Positive | |
Mar2021 | ₹-186 Cr | Negative | |
Mar2020 | ₹-251 Cr | - |
Compare Cash Flow from Financing Activities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹23,617.9 Cr | 13.5% | 6.7% | 54.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | 0.6% | -2.1% | 16.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | 4.3% | 6.5% | 63.9% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 3.6% | 0.2% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 3% | -8.4% | 0% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | 3.2% | -1% | 27.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 13.5% |
6.7% |
54.6% |
SENSEX | 0.5% |
0.3% |
7.9% |
You may also like the below Video Courses